BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 161 filers reported holding BIODELIVERY SCIENCES INTL IN in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $181,000 | +182.8% | 58,917 | +234.8% | 0.00% | – |
| Q2 2021 | $64,000 | +56.1% | 17,600 | +59.8% | 0.00% | – |
| Q1 2021 | $41,000 | -75.7% | 11,017 | -72.2% | 0.00% | – |
| Q4 2020 | $169,000 | +98.8% | 39,566 | +75.1% | 0.00% | – |
| Q3 2020 | $85,000 | -76.6% | 22,600 | -76.7% | 0.00% | -100.0% |
| Q1 2020 | $363,000 | +114.8% | 97,198 | +264.0% | 0.00% | – |
| Q4 2019 | $169,000 | +30.0% | 26,700 | -32.6% | 0.00% | – |
| Q4 2018 | $130,000 | +348.3% | 39,600 | +204.6% | 0.00% | – |
| Q2 2018 | $29,000 | 0.0% | 13,000 | 0.0% | 0.00% | – |
| Q1 2018 | $29,000 | -62.8% | 13,000 | -50.6% | 0.00% | – |
| Q4 2017 | $78,000 | -38.6% | 26,300 | -38.8% | 0.00% | – |
| Q3 2017 | $127,000 | -13.6% | 43,000 | -17.7% | 0.00% | – |
| Q2 2017 | $147,000 | +129.7% | 52,274 | +42.7% | 0.00% | – |
| Q4 2016 | $64,000 | -69.2% | 36,630 | -51.8% | 0.00% | -100.0% |
| Q3 2016 | $208,000 | +101.9% | 76,004 | +79.4% | 0.00% | – |
| Q2 2016 | $103,000 | – | 42,357 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,575,000 | $6,615,000 | 4.38% |
| 1492 Capital Management LLC | 790,863 | $3,322,000 | 1.91% |
| Rubric Capital Management LP | 3,516,124 | $14,768,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $40,026,000 | 0.79% |
| Zebra Capital Management LLC | 144,241 | $606,000 | 0.77% |
| KNOTT DAVID M | 370,230 | $1,555,000 | 0.70% |
| Nantahala Capital Management | 5,123,671 | $21,519,000 | 0.67% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,593,893 | $15,094,000 | 0.66% |
| EMC Capital Management | 98,933 | $416,000 | 0.32% |
| ALGERT GLOBAL LLC | 175,170 | $736,000 | 0.21% |